참고문헌
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424 https://doi.org/10.3322/caac.21492
- Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. PLoS One 2015;10:e0121323
- Chan BA, Hughes BG. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res 2015;4:36-54
- Pinsky PF, Church TR, Izmirlian G, Kramer BS. The national lung screening trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013;119:3976-3983 https://doi.org/10.1002/cncr.28326
- Mizuno T, Masaoka A, Ichimura H, Shibata K, Tanaka H, Niwa H. Comparison of actual survivorship after treatment with survivorship predicted by actual tumor-volume doubling time from tumor diameter at first observation. Cancer 1984;53:2716-2720 https://doi.org/10.1002/1097-0142(19840615)53:12<2716::AID-CNCR2820531227>3.0.CO;2-N
- Arai T, Kuroishi T, Saito Y, Kurita Y, Naruke T, Kaneko M. Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Jpn J Clin Oncol 1994;24:199-204
- Honda O, Johkoh T, Sekiguchi J, Tomiyama N, Mihara N, Sumikawa H, et al. Doubling time of lung cancer determined using three-dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma. Lung Cancer 2009;66:211-217 https://doi.org/10.1016/j.lungcan.2009.01.018
- Mackintosh JA, Marshall HM, Yang IA, Bowman RV, Fong KM. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer. Respirology 2014;19:755-762 https://doi.org/10.1111/resp.12311
- Obayashi K, Shimizu K, Nakazawa S, Nagashima T, Yajima T, Kosaka T, et al. The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer. J Thorac Dis 2018;10:5428-5434 https://doi.org/10.21037/jtd.2018.08.118
- Wilson DO, Ryan A, Fuhrman C, Schuchert M, Shapiro S, Siegfried JM, et al. Doubling times and CT screen-detected lung cancers in the Pittsburgh Lung Screening Study. Am J Respir Crit Care Med 2012;185:85-89 https://doi.org/10.1164/rccm.201107-1223OC
- Winer-Muram HT, Jennings SG, Tarver RD, Aisen AM, Tann M, Conces DJ, et al. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 2002;223:798-805 https://doi.org/10.1148/radiol.2233011026
- Lee HJ, Kim YT, Kang CH, Zhao B, Tan Y, Schwartz LH, et al. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes. Radiology 2013;268:254-264 https://doi.org/10.1148/radiol.13112553
- Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-285 https://doi.org/10.1097/JTO.0b013e318206a221
- Tsao MS, Marguet S, Le Teuff G, Lantuejoul S, Shepherd FA, Seymour L, et al. Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection. J Clin Oncol 2015;33:3439-3446 https://doi.org/10.1200/JCO.2014.58.8335
- Ujiie H, Kadota K, Chaft JE, Buitrago D, Sima CS, Lee MC, et al. Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival. J Clin Oncol 2015;33:2877-2884 https://doi.org/10.1200/JCO.2015.60.9818
- Wang L, Jiang W, Zhan C, Shi Y, Zhang Y, Lin Z, et al. Lymph node metastasis in clinical stage IA peripheral lung cancer. Lung Cancer 2015;90:41-46 https://doi.org/10.1016/j.lungcan.2015.07.003
- Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013;8:52-61 https://doi.org/10.1097/JTO.0b013e3182769aa8
- Devaraj A, van Ginneken B, Nair A, Baldwin D. Use of volumetry for lung nodule management: theory and practice. Radiology 2017;284:630-644 https://doi.org/10.1148/radiol.2017151022
- Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 1961;14:1272-1294 https://doi.org/10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H
- Jennings SG, Winer-Muram HT, Tann M, Ying J, Dowdeswell I. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology 2006;241:554-563 https://doi.org/10.1148/radiol.2412051185
- Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;242:555-562 https://doi.org/10.1148/radiol.2422052090
- Quint LE, Cheng J, Schipper M, Chang AC, Kalemkerian G. Lung lesion doubling times: values and variability based on method of volume determination. Clin Radiol 2008;63:41-48 https://doi.org/10.1016/j.crad.2007.07.011
- Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161-170 https://doi.org/10.1136/thoraxjnl-2015-207140
- Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-315 https://doi.org/10.1097/CEJ.0b013e328351e1b6
- van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-2229 https://doi.org/10.1056/NEJMoa0906085
- Mehrara E, Forssell-Aronsson E, Ahlman H, Bernhardt P. Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res 2007;67:3970-3975 https://doi.org/10.1158/0008-5472.CAN-06-3822
- Lee HJ, Goo JM, Lee CH, Park CM, Kim KG, Park EA, et al. Predictive CT findings of malignancy in ground-glass nodules on thin-section chest CT: the effects on radiologist performance. Eur Radiol 2009;19:552-560 https://doi.org/10.1007/s00330-008-1188-2
- Nakazono T, Sakao Y, Yamaguchi K, Imai S, Kumazoe H, Kudo S. Subtypes of peripheral adenocarcinoma of the lung: differentiation by thin-section CT. Eur Radiol 2005;15:1563-1568 https://doi.org/10.1007/s00330-004-2595-7
- Zwirewich CV, Vedal S, Miller RR, Muller NL. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991;179:469-476 https://doi.org/10.1148/radiology.179.2.2014294
- Sica G, Yoshizawa A, Sima CS, Azzoli CG, Downey RJ, Rusch VW, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010;34:1155-1162 https://doi.org/10.1097/PAS.0b013e3181e4ee32
- Suh YJ, Lee HJ, Kim YT, Kang CH, Park IK, Jeon YK, et al. Added prognostic value of CT characteristics and IASLC/ATS/ERS histologic subtype in surgically resected lung adenocarcinomas. Lung Cancer 2018;120:130-136 https://doi.org/10.1016/j.lungcan.2018.04.007
- Gao S, Stein S, Petre EN, Shady W, Durack JC, Ridge C, et al. Micropapillary and/or solid histologic subtype based on pre-treatment biopsy predicts local recurrence after thermal ablation of lung adenocarcinoma. Cardiovasc Intervent Radiol 2018;41:253-259 https://doi.org/10.1007/s00270-017-1760-8
- Leeman JE, Rimner A, Montecalvo J, Hsu M, Zhang Z, von Reibnitz D, et al. Histologic subtype in core lung biopsies of early-stage lung adenocarcinoma is a prognostic factor for treatment response and failure patterns after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2017;97:138-145 https://doi.org/10.1016/j.ijrobp.2016.09.037
- Nitadori J, Bograd AJ, Kadota K, Sima CS, Rizk NP, Morales EA, et al. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst 2013;105:1212-1220 https://doi.org/10.1093/jnci/djt166
- Huang KY, Ko PZ, Yao CW, Hsu CN, Fang HY, Tu CY, et al. Inaccuracy of lung adenocarcinoma subtyping using preoperative biopsy specimens. J Thorac Cardiovasc Surg 2017;154:332-339.e331 https://doi.org/10.1016/j.jtcvs.2017.02.059
- American College of Radiology. Lung CT screening reporting and data system (Lung-RADS). Acr.org Web site. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads. Accessed January 8, 2020
- Han D, Heuvelmans MA, Oudkerk M. Volume versus diameter assessment of small pulmonary nodules in CT lung cancer screening. Transl Lung Cancer Res 2017;6:52-61 https://doi.org/10.21037/tlcr.2017.01.05
- Kim H, Park CM. Current perspectives for the size measurement of screening-detected lung nodules. J Thorac Dis 2018;10:1242-1244 https://doi.org/10.21037/jtd.2018.03.24